These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 35199172

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Current concepts in the treatment of giant cell tumour of bone.
    van der Heijden L, Dijkstra S, van de Sande M, Gelderblom H.
    Curr Opin Oncol; 2020 Jul; 32(4):332-338. PubMed ID: 32541321
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Evaluation of Local Recurrence in Giant-Cell Tumor of Bone Treated by Neoadjuvant Denosumab.
    Chinder PS, Hindiskere S, Doddarangappa S, Pal U.
    Clin Orthop Surg; 2019 Sep; 11(3):352-360. PubMed ID: 31475058
    [Abstract] [Full Text] [Related]

  • 30. Association between preoperative denosumab and the risk of local recurrence in patients with giant cell tumor of bone: A meta-analysis and systematic review.
    Sun Z, Wu Z, Zhang L, Jia Q, Zhou Z, Xiao J.
    J Cancer Res Ther; 2023 Feb; 19(1):25-33. PubMed ID: 37006039
    [Abstract] [Full Text] [Related]

  • 31. Metastatic giant cell tumour of bone: a narrative review of management options and approaches.
    Xu R, Choong PFM.
    ANZ J Surg; 2022 Apr; 92(4):691-696. PubMed ID: 35143093
    [Abstract] [Full Text] [Related]

  • 32. Denosumab salvage therapy in an 11-year-old boy with locally recurrent unresectable giant cell tumor of the lumbar spine after surgery.
    Luo Y, Xiu P, Chen H, Zeng J, Song Y, Li T.
    Neurochirurgie; 2023 May; 69(3):101427. PubMed ID: 36828057
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The multidisciplinary management of giant cell tumor of bone.
    Ng VY, Davidson DJ, Kim EY, Pollack SM, Conrad Iii EU, Jones RL.
    Expert Rev Anticancer Ther; 2014 Jul; 14(7):783-90. PubMed ID: 24666240
    [Abstract] [Full Text] [Related]

  • 35. Objective tumor response to denosumab in patients with giant cell tumor of bone: a multicenter phase II trial.
    Ueda T, Morioka H, Nishida Y, Kakunaga S, Tsuchiya H, Matsumoto Y, Asami Y, Inoue T, Yoneda T.
    Ann Oncol; 2015 Oct; 26(10):2149-54. PubMed ID: 26205395
    [Abstract] [Full Text] [Related]

  • 36. A High-grade Sarcoma Arising in a Patient With Recurrent Benign Giant Cell Tumor of the Proximal Tibia While Receiving Treatment With Denosumab.
    Aponte-Tinao LA, Piuzzi NS, Roitman P, Farfalli GL.
    Clin Orthop Relat Res; 2015 Sep; 473(9):3050-5. PubMed ID: 25758379
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Clinical, radiological and pathological outcomes following treatment of primary giant cell tumour of bone with Denosumab.
    Murphy B, Vodanovich D, Spelman T, Gullifer J, Slavin J, Powell G, Pang G, Choong P.
    ANZ J Surg; 2020 Dec; 90(12):2553-2558. PubMed ID: 32767541
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.